Planta Med 2002; 68(9): 804-807
DOI: 10.1055/s-2002-34401
Original Paper
Biochem./Physiol.
© Georg Thieme Verlag Stuttgart · New York

Transport of Amentoflavone Across the Blood-Brain Barrier in vitro

H. Gutmann1 , R. Bruggisser2 , W. Schaffner2 , K. Bogman1 , A. Botomino1 , J. Drewe1
  • 1Dept. of Research and Div. of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland and Institute of Clinical Pharmacy, University of Basel, Switzerland
  • 2Department of Pharmacy, Institute of Pharmaceutical Biology, University of Basel, Switzerland
Further Information

Publication History

Received: December 19, 2001

Accepted: March 29, 2002

Publication Date:
30 September 2002 (online)

Preview

Abstract

The biflavone amentoflavone is an ingredient of Hypericum perforatum L. (Clusiaceae), a plant which is widely used for the treatment of mild to moderate depression. Amentoflavone inhibits the binding of flumazenil to the benzodiazepine binding site of the GABAA-receptor (IC50 = 14.9 nM). Since it has to pass the blood-brain barrier (BBB) before reaching this receptor, the penetration of [3 H]-amentoflavone through BBB was studied in an in vitro model consisting of primary cell cultures of porcine brain capillary endothelial cells (BCEC). Concentration-dependent uptake (37 - 2000 nM) was neither saturable nor temperature-sensitive indicating passive diffusion as the major uptake mechanism. This finding was confirmed by transport experiments through BCEC monolayers (> 2 % of applied dose was transported after 30 min). Co-administration of Hypericum extract increased amentoflavone transport significantly (amentoflavone alone: permeability coefficient Papp = 4.59·10-6 cm/s; co-administrated sucrose: Papp = 3.22·10-6 cm/s; amentoflavone together with hypericum: Papp = 6.74·10-6 cm/s, co-administrated sucrose Papp = 5.49·10-6 cm/s) indicating that Hypericum constituents enhance amentoflavone transport possibly by modulating paracellular permeability. Experiments with the P-glycoprotein (P-gp) overexpressing cell line P388-MDR showed that amentoflavone uptake was significantly enhanced by addition of the P-gp inhibitor verapamil, suggesting a P-gp mediated back-transport out of the cells. In conclusion, our findings show, that amentoflavone is able to pass the blood-brain barrier in vitro by passive diffusion.

References

Prof. Dr. J. Drewe

Department of Clinical Pharmacology and Toxicology

University Hospital/Kantonsspital

Petersgraben 4

4031 Basel, Switzerland

Email: juergen.drewe@unibas.ch